Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy
Author:
Affiliation:
1. Department of Nephrology; The First Affiliated Hospital of Zhengzhou University; Zhengzhou China
2. Department of Medicine; McMaster University; Hamilton Ontario Canada
3. Department of Nephrology; Nanyang Central Hospital; Nanyang China
Funder
National Basic Research Program of China 973 Program
The medical scientific research project of Henan Provincial Health Bureau
Publisher
Wiley
Subject
Nephrology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/nep.12359/fullpdf
Reference40 articles.
1. The commonest glomerulonephritis in the world: IgA nephropathy;D'Amico;Q. J. Med.,1987
2. IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States?;Julian;Am. J. Med.,1988
3. Worldwide perspective of IgA nephropathy;Levy;Am. J. Kidney Dis.,1988
4. The changing pattern of glomerulonephritis in Singapore over the past two decades;Woo;Clin. Nephrol.,1999
5. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases;Koyama;Am. J. Kidney Dis.,1997
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and safety of low-dose corticosteroids combined with leflunomide for progressive IgA nephropathy: a systematic review and meta-analysis;BMC Urology;2024-03-11
2. Non-immunosuppressive treatment for IgA nephropathy;Cochrane Database of Systematic Reviews;2024-02-01
3. The efficacy and safety of hydroxychloroquine versus leflunomide in patients with IgA nephropathy: a single-center experience;Journal of Nephrology;2024-01-16
4. P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage-to-myofibroblast transition;Molecular Therapy;2022-09
5. Valsartan in Combination with Tripterygium Glycosides Protects against Chronic Nephritis via the Toll-Like Receptor 4 Pathway;Analytical Cellular Pathology;2022-08-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3